Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Sarama Completes Tranche 2 Options Placement

by admin February 11, 2025
February 11, 2025
Sarama Completes Tranche 2 Options Placement

Sarama Resources (SRR:AU) has announced Sarama Completes Tranche 2 Options Placement

Download the PDF here.

This post appeared first on investingnews.com

previous post
Crypto Market Recap: Saylor’s Strategy Resumes Bitcoin Buying
next post
When is the Starlink IPO Date and Can You Invest?

Related Posts

10 Silver ETFs for Every Investing Style in...

December 2, 2025

A$2.7m Equity Placement to Fund Laverton Drilling Campaign

June 30, 2025

Skyharbour’s Partner North Shore Uranium Signs Exploration Agreement...

March 21, 2025

Crypto Market Update: Stablecoin Funding Hits Record, Ethereum...

September 20, 2025

Radisson Awarded UL ECOLOGO Certification for Responsible Mineral...

March 5, 2025

Jeffrey Christian: Gold, Silver, PGMs in 2025; Plus...

March 15, 2025

Silo Wellness Submits CSE Listing Statement for Review...

September 29, 2025

Biotech Market Forecast: Top Trends for Biotech in...

January 24, 2025

Albemarle Swings to Profit, Lowers Spending Amid Prolonged...

August 2, 2025

Top 4 Canadian Biotech Stocks of 2025

October 24, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved